z-logo
open-access-imgOpen Access
The Case for Selective Withdrawal of Antidepressants in Patients with Advanced Kidney Disease
Author(s) -
Joseph Chilcot,
Ken Farrington
Publication year - 2019
Publication title -
journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.451
H-Index - 279
eISSN - 1533-3450
pISSN - 1046-6673
DOI - 10.1681/asn.2019030308
Subject(s) - escitalopram , sertraline , medicine , citalopram , randomized controlled trial , kidney disease , dialysis , paroxetine , comorbidity , adverse effect , context (archaeology) , antidepressant , psychiatry , paleontology , biology , hippocampus

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom